MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AdvisorShares Psychedelics ETF (NY:PSIL)

20.00 -0.84 (-4.03%)
Streaming Delayed Price Updated: 12:43 PM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,338
Open 20.46
Bid (Size) 19.92 (100)
Ask (Size) 19.97 (600)
Prev. Close 20.84
Today's Range 20.00 - 20.57
52wk Range 13.40 - 22.49
Shares Outstanding 7,499
Dividend Yield 33.68%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
These 3 Psychedelic Stocks Activated After Trump's Executive Order ↗
Via MarketBeat
Topics Government
News headline image
RLMD Stock Soars Pre-Market: Phase 2 Bladder Cancer Trial Data Impresses Investors ↗
Relmada stated that the therapy showed a 76% complete response rate at 12 months in high-risk non-muscle invasive bladder cancer. 
Via Stocktwits

Performance

YTD
+16.3%
+16.3%
1 Month
-1.6%
-1.6%
3 Month
+21.4%
+21.4%
6 Month
+5.6%
+5.6%
1 Year
+46.9%
+46.9%

More News

Read More
News headline image
Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises ↗
Via Stocktwits
Topics Intellectual Property
News headline image
HELP Stock Rallies After Experimental Depression Drug Reduces Symptoms In Study: Retail Thinks Its ‘Time To Buy More’ ↗
Via Stocktwits
NEUP Shares Rise Pre-Market As It Explores Strategic Alternatives, Including Potential Acquisition ↗
Via Stocktwits
News headline image
CMPS Stock Rises 23% Pre-Market As Compass Achieves Primary Endpoint In Phase 3 Treatment-Resistant Depression Trial ↗
Via Stocktwits
News headline image
CMPS Stock Jumps 22% Pre-Market As Compass Sets Timeline For New Phase 3 Depression Trial Results ↗
Via Stocktwits
News headline image
Psychedelics Break Out Of The Fringe Under RFK Jr’s 2025 Reset — But Did MNMD Or CMPS Own The Year? ↗
Via Stocktwits
Topics ETFs
News headline image
Optimism Flows From Pot To Psychedelics: Atai Beckley, Supernus Stocks Rise After Analyst Flags Positive Tailwinds From Trump’s Marijuana Order ↗
Via Stocktwits
Topics Cannabis ETFs Government
News headline image
Why Did KTTA Stock Soar A Whopping 48% Today? ↗
Via Stocktwits
News headline image
Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug ↗
Via Benzinga
News headline image
Compass Pathways Stock Slumps After Positive Late-Stage Trial Results From Psychedelic Drug ‘Underwhelm’ Analysts ↗
Via Stocktwits
News headline image
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors ↗
Via Benzinga
Topics Government
News headline image
5 ETFs That Beat Market Turmoil With Gains Last Week ↗
Via Benzinga
Topics ETFs Economy
News headline image
High-Momentum ETFs Leading the Market This Year
Via MarketBeat
Topics ETFs
News headline image
Small-Cap NRx Pharma’s Stock Draws Heavy Retail Buzz After Securing $27M Funding ↗
Via Stocktwits
News headline image
Mind Medicine Stock Rises As Evercore Projects 200% Upside On LSD Formulation: Retail Turns Bullish ↗
Via Stocktwits
News headline image
5 Best-Performing Sector ETFs Of Q4 ↗
Via Talk Markets
Topics ETFs
News headline image
Why Is Penny Stock Clearmind Gaining Today? ↗
Via Benzinga
News headline image
5 Best-Performing Sector ETFs Midway In Q4 ↗
Via Talk Markets
Topics ETFs
News headline image
Top And Flop ETFs Of The First Half ↗
Via Talk Markets
Topics ETFs
News headline image
Best And Worst ETF Zones Of Q2 ↗
Via Talk Markets
Topics Artificial Intelligence ETFs Economy
News headline image
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment ↗
Via Benzinga
News headline image
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More ↗
Via Benzinga
News headline image
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence ↗
Via Benzinga

Frequently Asked Questions

Is AdvisorShares Psychedelics ETF publicly traded?
Yes, AdvisorShares Psychedelics ETF is publicly traded.
What exchange does AdvisorShares Psychedelics ETF trade on?
AdvisorShares Psychedelics ETF trades on the New York Stock Exchange
What is the ticker symbol for AdvisorShares Psychedelics ETF?
The ticker symbol for AdvisorShares Psychedelics ETF is PSIL on the New York Stock Exchange
What is the current price of AdvisorShares Psychedelics ETF?
The current price of AdvisorShares Psychedelics ETF is 20.00
When was AdvisorShares Psychedelics ETF last traded?
The last trade of AdvisorShares Psychedelics ETF was at 06/05/26 12:43 PM ET
What is the market capitalization of AdvisorShares Psychedelics ETF?
The market capitalization of AdvisorShares Psychedelics ETF is 149.98K
How many shares of AdvisorShares Psychedelics ETF are outstanding?
AdvisorShares Psychedelics ETF has 150K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story